Medical Product Distribution & Logistics

The contract entails the end-to-end distribution of pharmaceutical products from origin to designated government facilities under strict military compliance standards, requiring specialized packaging and labeling that ensure security, integrity, and regulatory adherence throughout the supply chain. All shipments must utilize the fastest available transportation methods, explicitly excluding parcel post, to guarantee rapid and reliable delivery while maintaining full traceability from source to destination. Executed as a subcontract under the Defense Logistics Agency of the Department of Defense, the work falls under NAICS code 424210 for pharmaceutical and bulk drug merchant wholesalers, indicating a focus on high-volume medical logistics. The performance location and point of contact remain unspecified, but the contract’s execution is tied to the DLA’s broader mission to support defense and military health systems with timely, secure, and auditable pharmaceutical delivery. The solicitation was posted in mid-2026, and the award reference links to a formal DLA contract record for compliance and tracking purposes.